Estrogen receptor expression in adrenocortical carcinoma

Journal of Zhejiang University: Science B

Volumn 10, Issue 1, 2009, Pages 1-6

  Shen, Xiao Cao ^a   Gu, Cai Xiao ^a   Qiu, Yi Qing ^a   Du, Chuan Jun ^a   Fu, Yan Biao ^a   Wu, Jian Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Adrenocortical carcinoma (ACC); Diagnosis; Estrogen receptor (ER); Treatment

Indexed keywords

ESTROGEN RECEPTOR;

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLOW UP; GENE EXPRESSION; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; CHINA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 58549098578     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0820072     Document Type: Article

References (16)

1. Allolio, B., Fassnacht, M., 2006. Adrenocortical carcinoma: Clinical update. J. Clin. Endocrinol. Metab., 91 (6):2027-2037. [doi:10.1210/ jc.2005-2639]
2. Chen, D.Y., Sosa, R.E., Scherr, D.S., 2004. Treatment of adrenocortical carcinoma: Contemporary outcomes. Current Urology Reports, 5 (1):65-72. [doi:10.1007/s11934-004-0014-x]
3. Colletti, R.B., Roberts, J.D., Devlin, J.T., Copeland, K.C., 1989. Effects of tamoxifen on insulin-like growth factor 1 in patients with breast cancer. Cancer Res., 49 (7):1882-1884.
4. Dackiw, A.P., Lee, J.E., Gagel, R.F., Evans, D.B., 2001. Adrenal cortical carcinoma. World J. Surg., 25 (7):914-926. [doi:10.1007/ s00268-001-0030-7]
5. Demeure, M.J., Somberg, L.B., 1998. Functioning and nonfunctioning adrenocortical carcinoma: Clinical presentation and therapeutic strategies. Surg. Oncol. Clin. N. Am., 7 (4):791-805.
6. Dickson, R.B., Lippman, M.E., 1987. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev., 8 (1):29-43.
7. Lingappa, V.R., Farey, K., 2001. Physiological Medicine: A Clinical Approach to Basic Medical Physiology. McGraw-Hill, p.584.
8. MacFarlane, D.A., 1958. Cancer of the adrenal cortex: The natural history, prognosis and treatment in the study of fifty-five cases. Ann. R. Coll. Surg. Engl., 23 (3):155-186.
9. Medeiros, L.J., Weiss, L.M., 1991. New development in the pathologic diagnosis of adrenal cortical neoplasms: A review. Am. J. Clin. Pathol., 97 (1):73-83.
10. Ng, L., Libertino, J.M., 2003. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J. Urol., 169 (1):5-11. [doi:10.1016/ S0022-5347(05)64023-2]
11. Osborne, C.K., Boldt, D.H., Clark, G.M., Trent, J.M., 1983. Effects of tamoxifen on human breast cancer cell kinetics: Accumulation of cells in early G1 phase. Cancer Res., 43 (8):3583-3585.
12. Pommier, R.F., Brennan, M.F., 1992. An eleven-year experience with adrenocortical carcinoma. Surgery, 112 (6):963-970.
13. Schteingart, D.E., Doherty, G.M., GAuger, P.G., Giordano, T.J., Hammer, G.D., Korobkin, M., Worden, F.P., 2005. Management of patients with adrenal cancer: Recommendations of an international consensus conference. Endocr. Relat. Cancer, 12 (3):667-680. [doi:10.1677/ erc.1.01029]
14. Schulick, R.D., Brennan, M.F., 1999. Adrenocortical carcinoma. World J. Urol., 17 (1):26-34. [doi:10.1007/s003450050101]
15. Sullivan, M., 1978. Adrenal cortical carcinoma. Urology, 120 (6):660-665.
16. Weiss, L.M., 1984. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol., 8 (3):163.